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Structural and functional studies of the gene coding for the low density 
lipoprotein receptor in patients with familial hypercholesterolemia have 
uncovered over 180 mutant alleles of the gene. Although the classical 
familial hypercholesterolemia phenotype is well known, the range of 
phenotypic variability in lipid traits associated with particular muta- 
tions in familial hypercholesterolemia has not been extensively docu- 
mented. We investigated the phenotypic distributions of plasma markers 
of lipid metabolism from a large sample of unrelated individuals who are 
heterozygous for a single mutation, a >10 kb deletion in the low den- 
sity lipoprotein receptor gene, and compared these distributions with 
those from a sample of healthy controls. Patients were pair-matched for 
sex and age with healthy individuals selected from a previously studied 
French-Canadian population from the same region. We examined the 
level and variation of seven lipid traits, the correlations between the 
traits, and the amount of overlap of the sample distributions for each 
trait. The low density lipoprotein receptor defect was found to affect 
the levels and variability of traits, and correlations between traits. There 
was some overlap of the distributions of lipid traits including that for 
low density lipoprotein cholesterol, which is a cardinal feature of fam- 
ilial hypercholesterolemia. The low density lipoprotein receptor gene 
has a sex-specific pleiotropic effect and should be considered as a vari- 
ability gene as well as a level gene. The extensive dynamic changes 
observed in the relationships between lipid traits testify to the biological 
complexity of genome type-environment interactions. 
As much as 50% of the variability in total plasma 
cholesterol (T-CHOL) level among individuals in 
the general population is associated with genetic 
variation (Sing & Boerwinkle 1987, Sing et al. 
1992). Individual specific, familial and shared en- 
vironmental influences attributable to diet, physi- 
cal activity and smoking behavior, together with 
measurement errors, account for the remainder. 
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Allelic variation at many genetic loci has been put 
forward as an explanation for the genetic compon- 
ent of interindividual variation in each of the 
plasma measures of lipid metabolism (Sing & Moll 
1990). On the other hand, mutations in a few genes 
known to contribute to this metabolism are be- 
lieved to be the cause of large phenotypic effects. 
For example, certain mutations in the gene coding 
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for the low density lipoprotein receptor (LDL-R) 
have large effects on the plasma level of low den- 
sity lipoprotein cholesterol (LDL-C) in patients 
with familial hypercholesterolemia (FH) (Hobbs et 
al. 1990). 
Studies of patients with homozygous FH have 
revealed considerable genetic heterogeneity: there 
may be as many as 183 different alleles of this gene 
(Hobbs et al. 1990). These defective alleles have 
been subdivided into five functional classes based 
on their effects on the LDL-R protein. The average 
LDL-C may exceed normal levels two- to three- 
fold in heterozygotes and as much as five- to six- 
fold in individuals with two defective alleles. Per- 
sons having such high plasma cholesterol levels 
have greatly increased risk of developing prema- 
ture coronary heart disease (CHD) (Goldstein & 
Brown 1989). 
Little is known about the range of phenotypic 
variation associated with any particular LDL-R 
mutation. Every person carrying the same defec- 
tive allele for the gene coding for the LDL-R is 
not expected to have the same plasma lipid levels 
or the same risk of developing CHD. This is be- 
cause variation at many genetic loci other than 
those within the region of the LDL-R gene, as 
well as environmental variation, also influence 
lipid metabolism. Studies to estimate the pen- 
etrance function, in FH patients, of specific LDL- 
R mutations have not been feasible because of 
the lack of large enough groups of patients carry- 
ing the same mutation. This limitation does not 
apply to one LDL-R mutation with a high preva- 
lence in the French-Canadian population because 
of a founder effect (BCtard et al. 1992). This 
mutation is defined by a >10 kb deletion (10 kb 
deletion) located in the 5’ region of the gene. The 
deletion removes the promoter and the first exon 
and results in an unexpressed allele (Hobbs et al. 
1987). 
The first object of the research reported here 
was to characterize the phenotypic distributions 
(penetrance function) of plasma measures of lipid 
metabolism for a large sample of unrelated indi- 
viduals who are heterozygous for the same 10 kb 
deletion in the LDL-R gene. The second object 
was to establish the proportion of individuals 
with this deletion whose measures of lipid metab- 
olism fall within the range of variability defined 
by a sample of healthy individuals. This ad- 
dressed the issue of whether hypercholesterolemia 
is a sensitive discriminator of individuals who 
carry the 10 kb deletion in French Canadians. We 
therefore measured the average plasma levels and 
the intra-genotypic variances and correlations of 
lipid traits for the 10 kb heterozygote sample and 
compared them with those of a sample of healthy 
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subjects without the deletion, drawn from the 
same ethnic group. 
Methods 
Sampling procedure 
Persons heterozygous for the 10 kb deletion were 
identified as described below through the lipid 
clinic at the Clinical Research Institute of Montre- 
al. This clinic serves the Montreal metropolitan 
area and surrounding region within a 50 km radius 
in the Province of Quebec, Canada. The vast ma- 
jority of patients attending this clinic are of French 
Canadian ancestry. In 1987, Hobbs et al. first de- 
scribed a >10 kb deletion in the LDL-R gene in 
patients with a clinical diagnosis of FH, drawn 
from the patient population of this clinic (Hobbs 
et al. 1987). Evidence showing this deletion to cor- 
respond with one haplotype defined by five LDL- 
R RFLPs was reported by Betard et al. (1992). 
Continued screening of all FH patients from this 
clinic confirmed that approximately 60% of 
French-Canadian FH patients carry this 10 kb de- 
letion in the 5’ end of the LDL-R gene. 
For this study, we selected 74 French-Canadian 
men and 72 women with the deletion, who were 
unrelated to the 3rd degree and had a diagnosis of 
FH (10 kb-FH) based on an elevated LDL-C level, 
the presence of tendon xanthomas in the patient 
(or a first-degree relative) and a personal or family 
history of premature CHD. We used baseline, 
treatment-free, lipid determinations from the first 
visit of each patient in the sample. However, these 
baseline measurements were made over a number 
of years and changed in detail with time as new 
techniques of lipid measurement became available. 
It was therefore impossible to include complete 
lipid data on all the 10 kb-FH individuals in the 
sample without seriously restricting the sample 
size. Among the 72 women in the 10 kb-FH 
sample, 11 were identified through a family mem- 
ber attending the clinic. The same holds true for 
16 of the 74 men who were studied. A small num- 
ber of patients were receiving lipid-lowering drugs 
prior to their initial evaluation. Any such medi- 
cation was withdrawn for a minimum of 1 month 
before baseline lipid level determination (none had 
been on probucol). Individuals who had under- 
gone partial ileal by-pass surgery, pregnant women 
and patients manifesting the severe FH phenotype 
associated with the presence of two defective LDL- 
R genes were excluded from the 10 kb-FH study 
group. No-one was excluded on the basis of any 
other medical condition or medication. 
A control group of healthy white-collar workers 
was selected to be sex and age-frequency matched 
(within 5 years) to members of the 10 kb-FH 
LDL-R gene: a level and variability gene 
sample. This sample, identified as the HQ sample 
from the name of the public utility where these in- 
dividuals worked, was selected from a larger 
sample of HQ workers who had participated in a 
study of healthy individuals described in detail by 
Xhignesse et al. (1991). Participants in that study 
had been selected for their health status, specifi- 
cally excluding pregnant women and those with 
known clinical manifestations of cardiovascular 
disease, hypertension, diabetes, thyroid dysfunc- 
tion, renal or liver dysfunction, hyperlipidemia (a 
posteriori hyperlipidemia was not excluded) and 
any chronic disorder requiring medication, abnor- 
mal or missing baseline liver or kidney function 
tests, or elevated blood glucose or uric acid levels. 
For the present study, all French Canadians in this 
sample were screened for the 10 kb deletion and 
another, infrequent, 5 kb deletion, both detected 
by the same restriction enzyme digests (Ma et al. 
1989). Neither deletion was detected in any of 
these individuals. 
Laboratory methods 
After a 12 h fast, blood samples for lipid, lipopro- 
tein and apolipoprotein determinations were ob- 
tained by peripheral venipuncture into tubes con- 
taining 1.5 m g / d  disodium ethylenediamine tetra- 
acetic acid (Na2EDTA), and were centrifuged 
within 2 h. Plasma lipoproteins were separated 
under standard conditions by a combination of ul- 
tracentrifugation and heparin-manganese precip- 
itation of the apo B-containing lipoproteins in the 
d= 1.006 g/l infranatant, according to the Lipid Re- 
search Clinics Protocol (Lipid Research Clinics Pro- 
gram, 1974). Plasma and lipoprotein cholesterol 
and triglycerides (TG) were measured enzy- 
matically on an automated analyzer (Technicon I 
before 1979, Abbott Bichromatic Analyzer 100, Ab- 
bott Laboratories, Pasadena, Ca.). Technicon meas- 
urements were adjusted according to a regression 
equation established from multiple interassay meas- 
urements comparing the two methods. A strict qual- 
ity control program was in effect in our laboratory 
and interassay variability was maintained at or be- 
low 5% while each method was used. Very low den- 
sity lipoprotein-apolipoprotein B (VLDL-B) and 
low density lipoprotein-apolipoprotein B (LDL-B) 
were measured by electroimmunoassay (Lussier- 
Cacan et al. 1985), using a commercial serum 
(Behringwerke, Marburg, West Germany) and a 
frozen serum pool as secondary standards. Routine 
biochemistry analyses including SMAC and liver 
function studies were also performed on blood 
drawn under the same fasting conditions. The pres- 
ence or absence of the 10 kb (and 5 kb) deletion was 
determined as described by Ma et al. (1989). 
Statistical methods 
The Statistical Analysis System, developed by the 
SAS Institute (SAS Institute Inc., 1989), was used. 
Since previous studies have shown that the fre- 
quency distributions for lipids, apolipoproteins 
and concomitants are sex-specific (Gordon et al. 
1977, Lipid Research Clinics Program Epidemi- 
ology Committee 1979, Abbott et al. 1983, Wilson 
et al. 1983, Reilly et a1 1990, Reilly et al. 1991, 
Sing & Reilly 1993), data for women and men were 
analyzed separately. The level of statistical signifi- 
cance was taken as 0.05. 
The means and variances of concomitants and 
of lipid, lipoprotein and apolipoprotein traits were 
compared for differences between the 10 kb-FH 
and HQ samples. When trait variances were found 
to be significantly different between the 10 kb-FH 
and HQ samples, the degrees of freedom for the 
t-tests of means were computed according to the 
formula given by Dixon & Massey (1969). An 
analysis of covariance was then carried out, separ- 
ately for women and men, to estimate the contri- 
bution of the concomitants to lipid, lipoprotein 
and apolipoprotein variation, and to test the hom- 
ogeneity of the regression equations between the 
10 kb-FH and HQ samples. Each lipid, lipoprotein 
and apolipoprotein trait was adjusted by the ap- 
propriate regression equation for variation in age, 
age squared, weight and height before comparing 
means, variances, and correlations between the 10 
kb-FH and HQ samples. When there was evidence 
for heterogeneity of regression between the 10 kb- 
FH and HQ samples, separate adjustments were 
carried out for each sample. The distributions of 
adjusted data were plotted as mmol/l or mg/dl 
(VLDL-B and LDL-B). 
Results 
Table 1 shows that average age and weight of men 
and women in the 10 kb-FH sample were not sig- 
nificantly different from those in the HQ sample. 
However, in both sexes, average height in the 10 
kb-FH sample was significantly lower than in the 
HQ sample, though without being significantly 
more variable within samples. In women, age is 
significantly more variable among members of the 
10 kb-FH sample than among members of the HQ 
sample. In both sexes, weight was significantly 
more variable within the 10 kb-FH sample. 
We removed the contribution of variation in age, 
age squared, weight and height to the variation in 
each of the lipid, lipoprotein and apolipoprotein 
traits. We found statistically significant heteroge- 
neity between the 10 kb-FH and HQ samples for 
the regression on these four concomitants for one 
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Table 1. Age, weight and height of 72 HO women and 74 HQ men (controls) and equal numbers of 10 kb-FH (patients) 
~ 
HI1 10 kb-FH pvalue 
Variable n Mean Variance n Mean Variance f-test of means F-test of variance 
WOMEN 
Age (yr) 72 37.04 52.660 72 39.50 123.324 0.1184 0.0004 
Weight (kg) 72 58.43 48.744 72 58.23 11 2.852 0.8907 0.0005 
Height (m) 72 1.61 0.003 72 1.57 0.003 0.0002 0.7692 
MEN 
Age (Yr) 74 35.74 57.755 74 34.92 73.144 0.5364 0.31 50 
Weight (kg) 74 74.05 78.742 74 73.33 149.359 0.6845 0.0069 
Height (m) 74 1.74 0.004 74 1.72 0.004 0.0170 0.5202 
or more of the lipid traits, for women and men 
considered separately. This justified separate ad- 
justments for each sample for all traits. 
Table 2 presents the means and variances of the 
adjusted data (unadjusted data not presented; ad- 
justed data identified by prefix A). As expected, the 
variances of the lipid, lipoprotein and apolipopro- 
tein traits were reduced after adjustment in each 
sample for both sexes, so that the adjustments in- 
creased the level of statistical significance for dif- 
ferences between the group means. The increase in 
statistical significance for the tests of the differ- 
ences between the two groups suggests greater 
heterogeneity of the variances after removal of 
variation in concomitants. As we observed for the 
unadjusted high density lipoprotein cholesterol 
(HDL-C) data, the difference between the variance 
of AHDL-C for the 10 kb-FH and HQ samples in 
men did not reach statistical significance. However, 
taking the means into account, the coefficients of 
variation were large and showed that the vari- 
ability of the AT-CHOL and AHDL-C tended to 
be similar for the 10 kb-FH and HQ samples of 
both sexes and that the variability of the ALDL-C 
and ALDL-B were smaller for the 10 kb-FH 
samples. 
Fig. 1 is a diagrammatic representation of the 
statistically significant (at the 0.01 level of prob- 
ability) pairwise correlations between adjusted 
lipid, lipoprotein and apolipoprotein traits. As ex- 
pected, there is a positive correlation between ATG 
and AVLDL-C and AVLDL-B in women and men 
in both samples; the same is true for ALDL-C and 
ALDL-B. AHDL-C and ATG are not correlated 
except for a weak negative correlation in the HQ 
women sample. In the female samples, there is a 










HQ 10 kb-FH 
Coefficient of Coefficient of 
n Mean Variance variation Yo n Mean Variance variation Yo 
pvalue 
t-test of F-test of 
means variance 
72 4.75 0.495 14.87 72 9.95 2.146 14.77 
72 0.77 0.103 41.82 72 1.77 1.092 59.25 
72 1.31 0.084 22.20 67 1.00 0.043 20.82 
72 2.98 0.402 21.35 67 7.85 1.538 15.86 
72 0.45 0.036 42.31 67 0.97 0.268 53.57 
72 96.24 373.970 20.16 52 220.62 956.791 14.09 
















74 4.81 0.720 17.70 74 9.56 1.640 13.45 0.0001 
74 1.02 0.170 40.56 74 1.78 0.757 49.05 0.0001 
74 1.08 0.048 20.36 68 0.84 0.044 25.06 0.0001 
74 3.14 0.615 25.06 68 7.59 1.680 17.14 0.0001 
74 0.59 0.046 36.77 68 1.16 0.557 64.58 0.0001 
74 103.93 566.337 22.98 58 221.40 1367.048 16.77 0.0001 








'AT-CHOL, adjusted total cholesterol; ATG, adjusted triglycerides; AHDL-C, adjusted high density lipoprotein cholesterol; ALDL-C, adjusted low density lipoprotein 
cholesterol; AVLDL-C, adjusted very low density lipoprotein cholesterol; ALDL-B, adjusted apolipoprotein B of low density lipoprotein; AVLDL-B, adjusted apolipo- 
protein B of very low density lipoprotein, mmll, millimole per liter; mg/dl, milligram per deciliter. 
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Fig. 1. Statistically significant Pearson product correlations where - - represents a correlation between -0.5 and -0.3, - repre- 
sents a correlation between 0.3 and 0.5, - represents a correlation between 0.5 and 0.7 and m represents a correlation between 
0.7 and 1.0. 
weak positive correlation between ALDL-B and 
ATG, whereas ALDL-B and AVLDL-C are 
weakly correlated in the 10 kb-FH sample only. 
In men, the HQ sample shows correlation between 
ALDL-B and ATG and between ALDL-B and 
AVLDL-C which are absent in the 10 kb-FH 
sample, and there is a weak negative correlation 
between ALDL-C and AVLDL-C in the 10 kb-FH 
sample which is absent in the HQ sample. 
Contrasting the strength of the correlations by 
computing their differences (HQ minus 10 kb-FH) 
shows that in women, only the negative difference 
between the AHDL-C - ATG correlations is statis- 
tically significant (at the 0.05 level of probability). 
For the men, the difference in strength of the corre- 
lations between lipid traits is significant for 
AHDL-C - AVLDL-C (weaker in HQ), ATG - 
ALDL-C, ALDL-C - AVLDL-B and ALDL-B - 
AVLDL-B (stronger in HQ), traits between which 
there is no significant correlation within each 
sample. The difference is also significant for corre- 
lations between ATG - ALDL-B and AVLDL-C - 
ALDL-B that are weakly significant in the HQ but 
not in the 10 kb-FH sample, between ALDL-C - 
AVLDL-C that is weakly significant in the 10 kb- 
FH but not in the HQ sample and between 
AVLDL-C - AVLDL-B (weaker in HQ). 
Again considering sexes separately, the fre- 
quency distributions of adjusted data are plotted 
in Fig. 2 to illustrate the observed dispersion of 
values and the extent of overlap of the 10 kb-FH 
with the HQ sample. In women, there was only 
1%, 0% and 2% overlap respectively for AT-CHOL, 
ALDL-C and ALDL-B. There was considerable 
overlap of the AHDL-C distributions, with lower 
values more frequent in the 10 kb-FH sample al- 
though 3% of values in the HQ distribution were 
at or below the 20th percentile of the 10 kb-FH 
distribution. For ATG, AVLDL-C and AVLDL-B, 
all values in the HQ sample fell within the range 
of values in the 10 kb-FH sample. However, be- 
cause of the greater skewness of the frequency dis- 
tribution of the 10 kb-FH sample, only O%, 1% 
and 0% of the respective HQ values fell at or above 
the 80th percentile of the 10 kb-FH distributions. 
In men, the overlap for AT-CHOL, ALDL-C and 
ALDL-B was 1%, 1% and 9% respectively (confi- 
dence interval 0.0125 to 0.1599 for ALDL-B). 
Other observations followed those for women, 
with considerable overlap of the AHDL-C distri- 
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butions, lower values being more frequent in the 
10 kb-FH sample, although 5% of values in the 
HQ distribution were at or below the 20th percen- 
tile of the 10 kb-FH distribution. For ATG, 
AVLDL-C and AVLDL-B, all values observed in 
the HQ sample fell within the range of values ob- 
served in the 10 kb-FH sample. Again because of 
the greater skewness of the frequency distribution 
of values in the 10 kb-FH sample, only 4%, 0% 
Fig. 2. Frequency distibution of 
adjusted data by sex where H 
represents the 10 kb-FH distri- 
bution and 0 represents the HQ 
distribution. 
and 0% of HQ values fell at or above the 80th per- 
centile of the 10 kb-FH distributions. 
Discussion 
The strong influence of mutations in the LDL-R 
gene on LDL-C and LDL-B levels is well known, 
but the extent of the variation in lipid, lipoprotein 
and apolipoprotein traits in FH patients and the 
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pressed allele, these patients are functional hemizy- 
gotes (Hobbs et al. 1990). Their LDL-C level is 
likely to be influenced strongly by the LDL-R al- 
lele without the 10 kb deletion, and by other gen- 
etic and environmental factors specific to the indi- 
vidual. 
The means of other lipid traits were also consist- 
ent with published values for FH patients. The 
ATG, AVLDL-C and AVLDL-B means of the HQ 
samples of both sexes are lower and AHDL-C 
means higher, reflecting the selection criteria of the 
healthy samples. HDL-C levels have been reported 
to be lower on average in FH individuals, whatever 
their age (Gagne et al. 1979) and in patients with 
coronary artery disease (Frohlich et al. 1989, Hill 
et al. 1991). Since many of the FH patients come 
to medical attention because of cardiac problems, 
this may constitute a selection bias which cannot 
be quantified. 
The lipid and apolipoprotein trait variances are 
greater in the 10 kb-FH than in the HQ samples, 
except for AHDL-C where the difference is sig- 
nificantly greater in the HQ women sample and 
not significantly different between the HQ men 
samples. The selection bias mentioned above may 
contribute to this finding. Thus, the variability ob- 
served in the 10 kb-FH women and men samples 
is greater than that observed in the corresponding 
healthy samples. However, when the means of the 
samples are taken into account by computing the 
coefficient of variation, the variability of ALDL-C 
and ALDL-B levels proved to be smaller in the 
presence of the 10 kb deletion than in its absence, 
even though variability was curtailed by the ex- 
clusion of diseased and/or previously diagnosed 
hyperlipidemic individuals from the healthy 
samples. The coefficient of variation for AHDL-C 
levels shows that in fact the variability of this trait 
was similar in the 10 kbrFH and HQ women. 
The strong correlations between lipid traits ob- 
served in the healthy samples are present in the 10 
kb-FH samples, although their strength is altered in 
men. This is notably true of correlations between 
ALDL-C and ALDL-B, and between ATG and 
AVLDL-C and AVLDL-B, reflecting their close 
metabolic links. However, weaker correlations be- 
tween traits of cholesterol and triglyceride metab- 
olism are significantly more disrupted in 10 kb-FH 
men, suggesting a sex-dependent disturbance of 
homeostasis extending beyond the obviously altered 
LDL-C metabolism in FH individuals. 
Given the large variation in the levels of the traits 
in all samples, we observed overlap of the distri- 
butions of values between the HQ and 10 kb-FH 
samples for most traits. Overlapping of AHDL-C 
levels with lower values found in the 10 kb-FH 
samples is consistent with the literature on FH (Hill 
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associations between these traits have not been ex- 
plored within groups of patients carrying the same 
mutation. Availability of DNA typing offers an 
unprecedented opportunity to study the pen- 
etrance function of identical mutations in the 
LDL-R gene in individuals diagnosed as having 
FH. The particular genetic makeup of the French- 
Canadian population enabled us to document the 
range of phenotypic variability, in FH patients, as- 
sociated with a well-characterized mutation in the 
LDL-R gene, a >I0  kb deletion, which has a high 
prevalence in FH patients in this population. 
In this study, the subjects chosen were unrelated 
to the 3rd degree, in order to minimize the selec- 
tion bias pertaining to their common genetic back- 
ground, thus providing a better estimate of the 
phenotypic variability among FH subjects hetero- 
zygous for this 10 kb deletion. The variability we 
observed underestimates the true variability of 
phenotypes among subjects with the 10 kb deletion 
genotype in the general population. Since most pa- 
tients diagnosed as FH are referred to a specialized 
lipid clinic because of hyperlipidemia or heart dis- 
ease, some carriers may not come to medical atten- 
tion because of the presence of a milder phenotype. 
A small number of subjects with LDL-C levels in 
the normal range of variability, who are obligate 
heterozygotes for an LDL-R mutation and were 
identified through a family study because of a 
homozygous offspring, have been described in the 
literature (Nora et al. 1985, Hobbs et al. 1989, 
Uauy et al. 1991). 
There is no published report of extensive popu- 
lation screening, using molecular methods for gen- 
otyping, to assess the prevalence of a specific muta- 
tion known to cause FH in a particular ethnic 
group and to determine its true phenotypic vari- 
ability, i.e. penetrance function. Such a screening 
of the general population could also estimate the 
relative frequency of specific LDL-R mutations 
within the apparently healthy population at large. 
Table 1 shows that despite successful matching 
for age and weight, average height was significantly 
lower in the 10 kb-FH samples, which raises the 
possibility that the disturbance in lipid metabolism 
may have interfered in subtle ways with the growth 
process of the FH patients (Miettinen & Aro 
1972). The sampling procedure for obtaining the 
healthy group of individuals from which our HQ 
sample was drawn accounts for differences in vari- 
ability of age and weight between the samples. 
The 2- to 3-fold increase in the mean levels of 
ALDL-C and ALDL-B and the extent of vari- 
ability for these traits (Table 2) are similar to pre- 
vious reports of FH groups carrying undefined 
mutations (Thompson et al. 1989, Hobbs et al. 
1987). Since this 10 kb deletion results in an unex- 
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et al. 1991) and may in part be ascribed to a selec- 
tion bias, i.e. the diseased FH individuals, with 
lower HDL-C levels, having a greater probability of 
coming to medical attention than the healthy ones 
of the same age. For the AT-CHOL distributions in 
both sexes and ALDL-C distributions in men only, 
there is overlap of the upper tail of the HQ distri- 
butions with the lower tail of the 10 kb-FH distri- 
butions, illustrating the fact that these traits con- 
sidered alone are not indicators of the presence of 
the 10 kb deletion. Overlapping of the ALDL-B dis- 
tributions in both sexes suggests that high LDL-B 
values are common in a healthy population, par- 
ticularly in men, and that they are less prevalent in 
women, at least before the menopause. A strong 
atherogenic potential has been ascribed to increased 
levels of apolipoprotein B (Teng et al. 1986). The 
healthy individuals who have values of ALDL-B 
within the range of the 10 kb-FH distribution may 
be those who have a greater predisposition to CHD. 
Variation in the LDL-R gene determines large 
phenotypic effects (Goldstein & Brown 1989). The 
presence of this 10 kb deletion in the LDL-R gene 
has a major influence on one trait, LDL-C. There- 
fore, it is a “level” gene. But it is also a variability 
and a covariability gene, giving rise to dynamic 
changes in the variability and the relationships be- 
tween traits belonging to the same metabolic path- 
way (Berg 1990). These observations argue that this 
10 kb deletion in the LDL-R gene influences the 
phenotypic plasticity and coordinated metabolism 
of several lipid and lipoprotein traits. Inherent bio- 
logical interactions whose function is to maintain 
homeostasis are altered between related traits of 
lipid metabolism, so that the pattern of associations 
among the traits in the 10 kb-FH sample is different 
from that found in healthy individuals (Kozlowska 
et al. 1988, Reilly et al. 1994). Our study also shows 
that these alterations are sex-dependen t. 
Certain mutations may play a complex role in the 
coherence of the relationships between traits in the 
same metabolic pathway and in the adaptive system 
whose function is to maintain homeostasis (Sing & 
Davignon 1993). Therefore, the concept that one 
gene influences a single trait should be broadened to 
include the study of genotype-dependent profiles of 
means, variances and correlations between meta- 
bolically related traits. This approach will better ac- 
count for the phenotypic plasticity and the biologi- 
cal complexity of the relationships that we observe 
and will provide insights for modeling complicated 
gene effects. 
Since the gene effect is context-dependent, this 
pattern is in turn influenced by the “genome type”, 
or genetic background of the individual, and by ex- 
posure of the individual to the environment. Differ- 
ences in the genetic background between affected 
individuals will lead to individual specific variation 
in phenotypic expression. Moreover, variation in 
the environmental context over time can be ex- 
pected to induce dynamic changes in an extended 
network of intermediate traits as an adaptive re- 
sponse that is modulated by the genome type of the 
individual (Sing & Reilly 1993, Zerba & Sing 1993). 
The biochemical and physiological determinants of 
the phenotype are emergent properties of combi- 
nations of genes and environments ultimately speci- 
fying risk of disease (Sing et al. 1992, Sing & Reilly 
1993, Sing et al. 1993, Zerba & Sing 1993). 
In conclusion, we studied a major genetic defect, 
namely a mutation in the gene coding for the 
LDL-R resulting in an unexpressed allele, in order 
to estimate the impact of such a defect on pheno- 
typic variation in traits of lipid metabolism. We 
compared the penetrance function describing indi- 
viduals who are heterozygous for the same LDL- 
R mutation and diagnosed as FH, with that for a 
sample of healthy control individuals, from the 
same ethnic background, in whom the presence of 
this specific mutation has been excluded. This 
comparison has shown that, after adjustment for 
basic concomitants, the average levels and disper- 
sions of traits, as well as the associations between 
particular pairs of these traits, are affected by this 
major monogenic defect. A coherent network of 
intermediate traits of lipid metabolism is pro- 
foundly disturbed by variation at a single locus. 
The alterations observed in the penetrance func- 
tion of the gene are sex-dependent. This is import- 
ant in comprehending the emergent properties of 
this network when it is disturbed by a major muta- 
tion. Furthermore, comparison of the distri- 
butions of adjusted LDL-C and LDL-B between 
the healthy control and 10 kb-FH groups has 
shown overlap. The true penetrance function, with 
respect to lipid traits, which is associated with par- 
ticular mutations in the LDL-R gene, will only be 
assessed by population screening in populations 
with known high prevalence of the mutations. 
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